CSIMarket
 


Vir Biotechnology Inc   (VIR)
Other Ticker:  
 

Vir Biotechnology Inc 's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


Return On Assets (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Total Assets Change 125.59 % 147.64 % 154.24 % 112.71 % 28.3 %
Y / Y Net Income Change 58.76 % - - - -
Net Income (TTM) in Millions 1,143 1,078 1,216 529 -102
Return On Assets (TTM) 44.85 % 49.72 % 68.43 % 39.46 % -9.47 %
Total Ranking # 77 # 63 # 52 # 114 #
Total Assets (TTM) in Millions 2,730 2,619 2,887 1,954 1,210
Seq. Total Assets Change 4.24 % -9.29 % 47.73 % 61.48 % 14.43 %
Seq. Net Income Change - - -1.26 % 375.65 % 78.65 %


Roa Comment
Vir Biotechnology Inc yielded Return on Asset in III. Quarter below company average, at 44.85 %.

ROA detoriated compare to previous period, despite net income growth.

Within Healthcare sector 18 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from 63 to 77.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 4
Sector # 19
Overall # 77

Return On Assets Statistics
High Average Low
68.43 %
50.65 %
39.46 %
(Mar 31 2022)   (Dec 31 2021)


Financial Statements
Vir Biotechnology Inc 's Assets $ 2,730 Millions VIR's Balance sheet
Vir Biotechnology Inc 's Income $ 175 Millions Quarterly VIR's Income Statement
VIR's Income by Division See VIR's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019

FY

FY
Y / Y Total Assets Change 112.71 % 79.42 % - - -
Total Assets in Millions 1,954 919 512 0 0
Y / Y Net Income Change - - - - -
Net Income in Millions 529 -299 -175 0 0
Return On Assets 27.05 % -32.51 % -34.11 % - -




Roa Comment
In the fiscal year 2021 ROA improved to 27.05 % compare to previous year, due to annual net income growth of -276.98 % to $528.58 millions, while value of Vir Biotechnology Inc 's overall assets grew just by 112.71 % to $1,954.27 millions, compare to $1,954.27 a year before.


More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VIR's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for VIR's Competitors
Roa for Vir Biotechnology Inc 's Suppliers
Return On Asstes for VIR's Customers

You may also want to know
VIR's Roi VIR's Inventory Turnover Ratio VIR's Growth Rates VIR's Dividend Comparisons
VIR's Profitability Ratios VIR's Asset Turnover Ratio VIR's Dividend Growth
VIR's Roe VIR's Valuation Ratios VIR's Financial Strength Ratios VIR's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA
Chimerix inc   119.67 %
Acelrx Pharmaceuticals Inc  74.43 %
Avalo Therapeutics Inc   63.55 %
Vicarious Surgical Inc   60.82 %
Siga Technologies Inc  56.55 %
Sensus Healthcare Inc   54.20 %
Molecular Templates Inc   52.62 %
Biomx Inc   51.18 %
Kiniksa Pharmaceuticals Ltd   50.28 %
Omeros Corporation  50.09 %
Moderna Inc   45.09 %
Vir Biotechnology Inc   45.00 %
Glucotrack Inc   44.25 %
Science 37 Holdings Inc   43.49 %
Chemomab Therapeutics Ltd   42.10 %
Quest Patent Research Corp  40.43 %
Sesen Bio Inc   39.55 %
Intercept Pharmaceuticals inc   39.53 %
Harpoon Therapeutics Inc   38.19 %
Oncotelic Therapeutics Inc   35.42 %
Biofrontera Inc   34.40 %
Prophase Labs Inc   32.74 %
Cen Biotech Inc  32.09 %
Dynavax Technologies Corporation  31.51 %
Iteos Therapeutics Inc   31.38 %
Ethema Health Corporation   30.79 %
Harmony Biosciences Holdings inc   30.44 %
Innoviva Inc   29.71 %
Exelixis Inc   29.31 %
Reflect Scientific Inc   29.05 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HBUV's Profile

Stock Price

HBUV's Financials

Business Description

Fundamentals

Charts & Quotes

HBUV's News

Suppliers

HBUV's Competitors

Customers & Markets

Economic Indicators

HBUV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071